NovaQuest provides tailored capital solutions to animal health companies that develop and commercialize pharmaceuticals and vaccines as well as genetic, nutrition, and technology products that serve companion and production animals and their healthcare providers: veterinarians, livestock producers and companion animal families.
NovaQuest has the flexibility to make product-specific structured finance investments in pharmaceutical development and innovation as well as equity investments in compelling animal health companies.
NovaQuest’s goal is to bring innovation to animal health by providing meaningful capital to animal health companies through structured finance and/or equity investments in both companion and production animals.
Specific areas of interest include pharmaceuticals (small molecules, vaccines, biologics), nutritional health, technology, diagnostics, and genetics.
We are open to collaboration with investment bankers, consultants and animal health companies.
NovaQuest makes equity, equity-like, and product finance investments in animal health products, including, among others, therapeutic drugs, nutritional health, diagnostics, and genetics.
NovaQuest has the ability and willingness to underwrite and share in the development risk of products and companies while retaining structural flexibility.